Literature DB >> 33497764

Capturing patient experience: A qualitative study of change from NAFLD to MAFLD real-time feedback.

Shereen Abdel Alem1, Yasmine Gaber1, Mohamed Abdalla2, Ebada Said3, Yasser Fouad4.   

Abstract

Entities:  

Year:  2021        PMID： 33497764     DOI： 10.1016/j.jhep.2021.01.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

1.  Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.

Authors:  Laurens A van Kleef; Ibrahim Ayada; Louise J M Alferink; Qiuwei Pan; Robert J de Knegt
Journal:  Hepatology       Date:  2021-12-13       Impact factor: 17.298

2.  Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China.

Authors:  Jia-Ying Wei; Zhou Xu; Hao Li; Wen-Qin Du; Bai-Ling Niu; Shu Li; Shen Tian; Juan Wu; Yu-Ling Chen; Xin Li; Zi-Li Liu; Jun Xiao; Guo-Sheng Ren; Liang Ran; Ling-Quan Kong
Journal:  Int J Med Sci       Date:  2021-06-22       Impact factor: 3.738

Review 3.  Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science.

Authors:  Yasser Fouad; Melissa Palmer; Minjun Chen; Arie Regev; Rajarshi Banerjee; Rob Myers; Robert Riccio; Richard Torstenson; Ramy Younes; Puneet S Arora; Henrik Landgren; Morten A Karsdal; Martin Blake; David A Shapiro; Hans-Juergen Gruss; Muhammad Y Sheikh; Dina Attia; Steven Bollipo; Alastair D Smith; Bradley Freilich; Robert G Gish; Detlef Schuppan
Journal:  J Clin Transl Hepatol       Date:  2021-10-22

Review 4.  Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

Authors:  Huapeng Lin; Xinrong Zhang; Guanlin Li; Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  J Clin Transl Hepatol       Date:  2021-08-30

5.  Metabolic-associated Fatty Liver Disease.

Authors:  Ming-Hua Zheng
Journal:  J Clin Transl Hepatol       Date:  2021-11-09

Review 6.  Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update.

Authors:  Jawaher Alharthi; Mohammed Eslam
Journal:  J Clin Transl Hepatol       Date:  2021-10-13

7.  The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Yasser Fouad; Gamal Esmat; Reda Elwakil; Serag Zakaria; Ayman Yosry; Imam Waked; Maissa El-Razky; Wahid Doss; Magdy El-Serafy; Ebraheem Mostafa; Mahmood Anees; Mohamed A Sakr; Nadia AbdelAty; Ashraf Omar; Samy Zaki; Amgad Al-Zahaby; Hamdy Mahfouz; Maysaa Abdalla; Mahmoud Albendary; Abdel-Khalek Hamed; Ahmed Gomaa; Adel Hasan; Sherif Abdel-Baky; Medhat El Sahhar; Gamal Shiha; Dina Attia; Ebada Saeed; Enas Kamal; Shamardan Bazeed; Mai Mehrez; Shereen Abdelaleem; Yasmine Gaber; Mohammed Abdallah; Asmaa Salama; Doaa A Tawab; Shaymaa Nafady
Journal:  Saudi J Gastroenterol       Date:  2022 Jan-Feb       Impact factor: 2.485

8.  Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD).

Authors:  Nahum Méndez-Sánchez; Luis Enrique Díaz-Orozco
Journal:  Med Sci Monit       Date:  2021-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.